Company filings profile · CIK 0001618835
Evofem Biosciences, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Evofem Biosciences, Inc. (EVFM): 5 filings in the last 90 days vs 4 in the prior 90 (filing-velocity rising ↑ · 1.25×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.
Material 8-K events — Evofem Biosciences, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 23, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 20, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| May 18, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 19, 2026 | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 26, 2025 | Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits | ↗ |
| Nov 13, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Oct 20, 2025 | Termination of a Material Agreement; Item 5.07; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Oct 17, 2025 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 26, 2025 | Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Aug 14, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch Evofem Biosciences, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| No insider filings in the current window. | ||
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 10-Q | 10-Q | ↗ |
| Aug 4, 2026 | SCHEDULE 13D | ↗ | |
| Jul 20, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| May 18, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 15, 2026 | 10-Q | 10-Q | ↗ |
| Apr 30, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 19, 2026 | 8-K | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | 10-K | 10-K | ↗ |
| Jan 12, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 26, 2025 | 8-K | Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits | ↗ |
| Nov 13, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 13, 2025 | 10-Q | 10-Q | ↗ |
| Oct 29, 2025 | DEF 14A | DEF 14A | ↗ |
| Oct 20, 2025 | PRE 14A | PRE 14A | ↗ |
| Oct 20, 2025 | 8-K | Termination of a Material Agreement; Item 5.07; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Oct 17, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Sep 19, 2025 | DEFA14A | DEFA14A | ↗ |
| Sep 9, 2025 | DEFA14A | DEFA14A | ↗ |
| Sep 8, 2025 | DEFM14A | DEFM14A | ↗ |
| Aug 26, 2025 | PREM14A | PREM14A | ↗ |
| Aug 26, 2025 | 8-K | Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Aug 14, 2025 | 10-Q | 10-Q | ↗ |
| Aug 14, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 6, 2025 | DEF 14C | DEF 14C | ↗ |
| Jul 24, 2025 | PREM14A | PREM14A | ↗ |
| Jul 9, 2025 | PRE 14C | PRE 14C | ↗ |
| Jul 2, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 2, 2025 | D | Item 06b | ↗ |
| May 22, 2025 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 15, 2025 | 10-Q | ↗ | |
| May 15, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 8, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Apr 15, 2025 | D | Item 06b | ↗ |
| Apr 14, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Apr 3, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Mar 28, 2025 | 10-K/A | ↗ |